teaser
The BioIndustry Association (BIA) today welcomed the appointment of UK MEP Glenis Willmott as the rapporteur for the European Parliament on the proposed Clinical Trials Regulation.
Steve Bates, BIA Chief Executive Officer, commented:
“Glenis understand the concerns of the UK life science sector and has a strong track record of supporting medical research that can lead to life saving treatments. She understands how the existing rules have played a part in the number of clinical trials in Europe falling over recent years. So, I am delighted that she will be steering this crucial piece of legislation through the European Parliament.
“The proposed Regulation will save time, money and paperwork for companies wishing to run clinical trials across Europe, thus making it easier to develop innovative medicines for patients. Making Europe a globally attractive place to do clinical trials is essential to sustaining and creating high value life science jobs.”
